4°28′02″E / 52.1655°N 4.4673°E / 52.1655; 4.4673 Janssen Vaccines, formerly Crucell, is a biotechnology company specializing in vaccines and biopharmaceutical...

GAVI-supported countries to introduce the five-in-one vaccine. In May 2010, Crucell N.V. announced a US$110 million award from UNICEF to supply its pentavalent...

Filovirus vaccine and Crucell/Janssen's AdVac technology based on adenoviral vectors, Bavarian Nordic joined efforts with Crucell Holland B.V., one of...

Cilag AG Janssen Biotech (formerly Centocor) Janssen Vaccines (formerly Crucell) Tibotec The early roots of what would become Janssen Pharmaceuticals date...

continued through 2002.: 221  The United States and the Dutch company Crucell collaborated to begin development on an ebola vaccine in response.: 222 ...

of antigen adsorbed on aluminium hydroxide (0.3 mg Al). Epaxal: made by Crucell. Also sold under the brand names HAVpur and VIROHEP-A. This vaccine consists...

prevention of typhoid: the live, oral Ty21a vaccine (sold as Vivotif by Crucell Switzerland AG) and the injectable typhoid polysaccharide vaccine (sold...

Solutions and the Human Performance Institute. In October 2010, J&J acquired Crucell for $2.4 billion. The subsidiary operates as the centre for vaccines, within...

government had been interested in letting Crucell work together with the Netherlands Vaccine Institute [nl], with Crucell offering the Netherlands a rapid vaccine...

improve health for expectant mothers and their children. In May 2010, Crucell N.V. announced an additional US$110 million award from UNICEF to supply...

Galapagos Genomics NV was founded in 1999 as a joint venture between Crucell and Tibotec. The company later changed its name to Galapagos NV and completed...

research spin-offs. Prominent examples of university spin-offs are Genentech, Crucell, Lycos and Plastic Logic. In most countries, universities can claim the...

Corporation (1981–2006) Chiroscience (1991–1999) Covidien (2007–2015) Crucell (2000–2010) Cubist (1992–2015) Cutter (1897–1974) Cynapsus (1984–2016)...

Innovative medicine Actelion Alza Cilag Crucell Janssen Pharmaceuticals Janssen Biotech MorphoSys Ortho-McNeil Pharmaceutical Ortho-McNeil-Janssen Ortho...

to get the chemistry right with joint CEOs". Reuters. 2 December 2019. "Crucell Announces Nomination of Ronald Brus as CEO". Klaas Knot wordt nieuwe president...

founded in 2012 by Ronald Brus, former CEO of the biotechnology company Crucell. In the beginning of its existence, myTomorrows has been characterized...

mumps and rubella) at its Liverpool plant. Chiron in conjunction with Crucell (now part of Johnson & Johnson) developed a pentavalent vaccine called...

2016.1165908. PMC 4994731. PMID 27105067. Kirschweger G (January 2003). "Crucell: biopharmaceuticals--as human as they get". Molecular Therapy. 7 (1): 5–6...

Stolpe founded Galapagos NV in 1999 when he was recruited by the CEO of Crucell to set up a new genomics division for the company. He launched the division...

a second vaccine as boost) – the first based on AdVac technology from Crucell Holland B.V. (which is part of Janssen), the second based on the MVA-BN...

The Scripps Research Institute and the Dutch biopharmaceutical company, Crucell. Immunology Friesen RH, Koudstaal W, Koldijk MH, Weverling GJ, Brakenhoff...

Manufacturers AstraZeneca Bharat Biotech BioMérieux BioNTech CSL Limited Crucell Eli Lilly Emergent BioSolutions GlaxoSmithKline Intercell Johnson & Johnson...

Crucell...

Human embryonic kidney cells (HEK-293) Human embryonic retinal cells (Crucell's Per.C6) Human amniocyte cells (Glycotope and CEVEC)[citation needed] Cell-free...

Therapeutics, Cadent Therapeutics, Disarm Therapeutics, CoStim Pharmaceuticals, Crucell, deCODE genetics, Delinia, Exelixis, IFM Therapeutics Inc., Micromet, Momenta...

had all earned their wealth through the sale of biotechnology company Crucell. Valerio had worked with Plasterk in the 1990s, and Löwenberg had introduced...

Immunology. She moved to Crucell in 2010, which, at the time, was an independent biotechnology company. Two weeks later, Crucell was acquired by Janssen...

pursuing the vaccine as of 2009 and 2010 include Theraclone, VaxInnate, Crucell NV, Inovio Pharmaceuticals, Immune Targeting Systems (ITS) and iQur. In...

Introgene (1994), a biotech start-up that became the pharmaceutical company Crucell, now part of Johnson & Johnson, and a co-founder of the cancer immunotherapy...

antibody for the prophylaxis of rabies. It is under development by Sanofi/Crucell. International Nonproprietary Names for Pharmaceutical Substances (INN)...